反应 #1951023

ord-90a7db682acf44b597d4aebd4bdaa373

反应方程式

CO.O
MeOH H2O
O=Cc1c(Cl)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2cc(Cl)c(Cl)cc12
2,5,6-trichloro-3-formyl-1-(β-D-ribofuranosyl)indole
O=Cc1c(Cl)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2cc(Cl)c(Cl)cc12
2,5,6-Trichloro-3-formyl-1-(β-D-ribofuranosyl)indole
CON.Cl
methoxylamine hydrochloride
O=C([O-])O.[Na+]
sodium bicarbonate
CON=C=C1c2cc(Cl)c(Cl)cc2N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1Cl
4.30
收率 41.0%
CON=C=C1c2cc(Cl)c(Cl)cc2N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C1Cl
2,5,6-Trichloro-3-(N-methoxyiminomethylidene)-1-(β-D-ribofuranosyl)indole
收率 41.0%

反应条件

详细条件
See reaction.notes.procedure_details.

后处理

  1. 1
    其他the solvent was evaporated
  2. 2
    其他to provide a pale yellow residue
  3. 3
    萃取extracted with EtOAc (2×25 mL)
  4. 4
    洗涤The combined organic extracts were washed with brine (10 mL)
  5. 5
    干燥dried over MgSO4
  6. 6
    过滤filtered
  7. 7
    其他evaporated
  8. 8
    其他to yield a yellow residue
  9. 9
    其他evaporated
  10. 10
    其他to yield a white powder
  11. 11
    其他The powder was recrystallized from Et2O

实验过程

To a solution of 2,5,6-trichloro-3-formyl-1-(β-D-ribofuranosyl)indole (4.3, 103 mg, 0.27 mmol) in MeOH (5 mL) was added a solution of methoxylamine hydrochloride (27 mg, 0.32 mmol) and sodium bicarbonate (22 mg, 0.26 mmol) in water (1.0 mL). The resulting mixture was stirred at room temperature for 16 h, then the solvent was evaporated to provide a pale yellow residue. The residue was suspended in 10 mL of 5% aqueous sodium thiosulfate and extracted with EtOAc (2×25 mL). The combined organic extracts were washed with brine (10 mL), dried over MgSO4, filtered and evaporated to yield a yellow residue. The residue was subjected to column chromatography (40×350 mm) on C18 reverse-phase silica gel with 80% MeOH/H2O. The appropriate UV-active fractions were pooled and evaporated to yield a white powder. The powder was recrystallized from Et2O to yield 45 mg (41%) of 4.30 as a white crystalline solid: mp 197-198 C; Rf 0.4 (10% MeOH/CHCl3); 1H NMR (500 MHz, DMSO-d6) δ 8.57 (s, 1H), 8.27 (s, 1H), 8.17 (s, 1H), 5.93 (d, 1H), 5.42 (d, 1H, D2O exch.), 5.40 (t, 1H, D2O exch.), 5.27 (d, 1H, D2O exch.), 4.42 (q, 1H), 4.14 (m, 1H), 4.00 (d, 1H), 3.96 (s, 3H), 3.71 (m, 2H). 13C NMR (125 MHz, DMSO-d6) δ 141.84, 133.04, 129.74, 126.09, 125.03, 123.82, 121.70, 115.46, 105.59, 88.85, 86.13, 71.43, 69.65, 61.84, 61.09. HRMS (EI) m/z calcd. for C15H15Cl3N2O5 408.0047, found 408.0047. Anal calcd for C15H15Cl3N2O5: C, 43.98; H, 3.69; N, 6.84. Found: C, 43.79; H, 3.68; N, 6.61.

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US07625871B2uspto-grants-2009_12